Polymorph forms of (S)-2-((4-benzofuranyl)carbonylaminom ethyl)-1-((4-(2-methyl-5-(4-fluorophenyl) thiazolyl)carbonyl)piperidine

Details for Australian Patent Application No. 2008297126 (hide)

Owner Glaxo Group Limited

Inventors Kindon, Leanda Jane

Agent Davies Collison Cave

Pub. Number AU-A-2008297126

PCT Pub. Number WO2009/034133

Priority 0717882.5 13.09.07 GB

Filing date 11 September 2008

Wipo publication date 19 March 2009

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/034133 Priority application(s): WO2009/034133

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008297129-Pharmaceutical compound

2008297124-Method and arrangement for providing chalcogens